.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

2015 Update - Latest Advances in Breast Cancer Treatment

EP. 1: Introduction: Biomarkers in Breast Cancer

June 17th 2015

EP. 2: Multigene Panel Testing in Breast Cancer

June 17th 2015

EP. 3: Tumor-Infiltrating Lymphocytes in Breast Cancer

June 17th 2015

EP. 4: Palbociclib in Metastatic Breast Cancer

June 17th 2015

EP. 5: Fulvestrant in HR-Positive Breast Cancer

June 17th 2015

EP. 6: Improving Endocrine Treatment Decisions in ER+ Breast Cancer

June 17th 2015

EP. 7: Overcoming Resistance in Breast Cancer

June 17th 2015

EP. 8: Clinical Trials for HER2-Positive Breast Cancer

June 17th 2015

EP. 9: Neratinib in HER2-Positive Breast Cancer

June 17th 2015

EP. 10: TNT Study for Triple-Negative or BRCA1/2 Breast Cancer

June 17th 2015

EP. 11: Future Approaches in Breast Cancer

June 17th 2015